Antipsychotic monotherapy among outpatients with schizophrenia treated with olanzapine or risperidone in Japan: a health care database analysis

by Takahashi M, Flynn JA, Tanji Y, Ascher-Svanum H, Ye W, Conley RR
Published 2012

Long-term functional improvements in the 2-year treatment of schizophrenia outpatients with olanzapine long-acting injection

by Ascher-Svanum H, Novick D, Haro JM, Bertsch J, McDonnell D, Detke H
Published 2014

Comparison of patients undergoing switching versus augmentation of antipsychotic medications during treatment for schizophrenia

by Ascher-Svanum H, Brnabic AJM, Lawson AH, Kinon BJ, Stauffer VL, Feldman PD, Kelin K
Published 2012

Movement disorder profile and treatment outcomes in a one-year study of patients with schizophrenia

by Chen L, Ascher-Svanum H, Lawson A, Stauffer VL, Nyhuis A, Haynes V, Schuh K, Kinon BJ
Published 2013

Does participation in a weight control program also improve clinical and functional outcomes for Chinese patients with schizophrenia treated with olanzapine?

by Montgomery W, Treuer T, Ye W, Xue HB, Wu SH, Liu L, Kadziola Z, Stensl, MD, Ascher-Svanum H
Published 2014